HONG KONG, March 27, 2026 /PRNewswire/ -- Unisound (09678.HK) announced its audited annual results for the year ended December 31, 2025. As the Company's first annual results announcement since ...
Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 ...
Analyst/Investor Day March 31, 2026 12:00 PM EDTCompany ParticipantsAnoori Naughton - Vice President of Investor ...
ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in ...
From a governance and leadership standpoint, Brendan and I will continue in our current roles, ensuring continuity of strategy and execution. McCormick will remain globally headquartered in Hunt ...
In the topsy-turvy world of aviation, Willie Walsh, the sharpshooting incoming CEO of IndiGo, has a rather peculiar nickname: ...
McCormick & Company, Incorporated (NYSE:MKC) Q1 2026 Earnings Call Transcript March 31, 2026 McCormick & Company, Incorporated beats earnings expectations. Reported EPS is $0.66, expectations were $0.
MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") recently ...
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its ...
Background/aims Ocular surface infections remain a major cause of visual loss worldwide, yet diagnosis often relies on slow ...